Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin

Acta Biomaterialia

Volumn 10, Issue 8, 2014, Pages 3505-3512

  Nan, Kaihui ^a,b   Ma, Feiyan ^a   Hou, Huiyuan ^a   Freeman, William R ^a   Sailor, Michael J ^c   Cheng, Lingyun ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b WENZHOU MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Daunorubicin; Ocular drug delivery; Poly(dl lactide co glycolide); Porous silicon oxide

Indexed keywords

CONTROLLED DRUG DELIVERY; EMULSIFICATION; EMULSIONS; POROUS SILICON; SILICON COMPOUNDS; SILICON OXIDES; TARGETED DRUG DELIVERY;

COMPOSITE MICROSPHERES; DAUNORUBICIN; MEAN DIAMETER; MICRO PARTICLES; OCULAR DELIVERY; OCULAR DRUG DELIVERY; POLY(DL-LACTIDE-CO-GLYCOLIDE); POLY(DL-LACTIDE-COGLYCOLIDE); POROUS SILICON OXIDE; WATERSOLUBLE;

MICROSPHERES;

DAUNORUBICIN; MICROSPHERE; NANOMATERIAL; OIL; POLYGLACTIN; SILICON; SILICON OXIDE; UNCLASSIFIED DRUG; WATER; ANTIINFECTIVE AGENT; DELAYED RELEASE FORMULATION; LACTIC ACID; MICROCAPSULE; POLYGLYCOLIC ACID; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; SILICON DIOXIDE;

ARTICLE; BIOLOGICAL ACTIVITY; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; EMULSION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; IN VITRO STUDY; MICROSCOPY; NANOENCAPSULATION; PARTICLE SIZE; POROSITY; PRIORITY JOURNAL; SOLID; SUSTAINED DRUG RELEASE; SYNTHESIS; ABSORPTION; ADMINISTRATION AND DOSAGE; ADSORPTION; CHEMISTRY; DELAYED RELEASE FORMULATION; DIFFUSION; INTRAOCULAR DRUG ADMINISTRATION; MATERIALS TESTING; MICROCAPSULE;

ABSORPTION, PHYSICOCHEMICAL; ADMINISTRATION, OPHTHALMIC; ADSORPTION; ANTI-BACTERIAL AGENTS; CAPSULES; DAUNORUBICIN; DELAYED-ACTION PREPARATIONS; DIFFUSION; LACTIC ACID; MATERIALS TESTING; POLYGLYCOLIC ACID; POROSITY; SILICON DIOXIDE;

EID: 84903695887     PISSN: 17427061     EISSN: 18787568     Source Type: Journal    
DOI: 10.1016/j.actbio.2014.04.024     Document Type: Article

References (43)

1. J.C. Pastor Proliferative vitreoretinopathy: an overview Surv Ophthalmol 43 1998 3 18
2. P. Wiedemann, R.D. Hilgers, P. Bauer, and K. Heimann Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group Am J Ophthalmol 126 1998 550 559
3. K. Shinohara, M. Tanaka, T. Sakuma, and Y. Kobayashi Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy Ophthalmic Surg Lasers Imaging 34 2003 299 305
4. J.A. Khawly, P. Saloupis, D.L. Hatchell, and R. Machemer Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy Graefes Arch Clin Exp Ophthalmol 229 1991 464 467
5. E.P. Chen, U.H. Steinhorst, G.P. Samsa, P.T. Saloupis, and D.L. Hatchell The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy Invest Ophthalmol Vis Sci 33 1992 2160 2164
6. P. Wiedemann, N. Sorgente, C. Bekhor, R. Patterson, T. Tran, and S.J. Ryan Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo Invest Ophthalmol Vis Sci 26 1985 719 725
7. M. Santana, P. Wiedemann, M. Kirmani, D.S. Minckler, R. Patterson, and N. Sorgente et al. Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit Graefes Arch Clin Exp Ophthalmol 221 1984 210 213
8. H. Mietz, and K. Heimann Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease Br J Ophthalmol 79 1995 874 877
9. A. Tzur-Balter, A. Gilert, N. Massad-Ivanir, and E. Segal Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride Acta Biomater 9 2013 6208 6217
10. J. Chhablani, A. Nieto, H.Y. Hou, E.C. Wu, W.R. Freeman, and M.J. Sailor et al. Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system Invest Ophthalmol Vis Sci 54 2013 1268 1279
11. S.H.C. Anderson, H. Elliott, D.J. Wallis, L.T. Canham, and J.J. Powell Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions Phys Status Solidi A 197 2003 331 335
12. A. Nieto, H. Hou, M.J. Sailor, W.R. Freeman, and L. Cheng Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles Exp Eye Res 116 2013 161 168
13. M.P. Stewart, and J.M. Buriak Chemical and biological applications of porous silicon technology Adv Mater 12 2000 859 869
14. K.I. Hartmann, A. Nieto, E.C. Wu, W.R. Freeman, J.S. Kim, and J. Chhablani et al. Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin J Ocul Pharmacol Ther 29 2013 493 500
15. L. Cheng, E. Anglin, F. Cunin, D. Kim, M.J. Sailor, and I. Falkenstein et al. Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle Br J Ophthalmol 92 2008 705 711
16. E.J. Anglin, M.P. Schwartz, V.P. Ng, L.A. Perelman, and M.J. Sailor Engineering the chemistry and nanostructure of porous silicon Fabry-Pérot films for loading and release of a steroid Langmuir 20 2004 11264 11269
17. J.S. Andrew, E.J. Anglin, E.C. Wu, M.Y. Chen, L.Y. Cheng, and W.R. Freeman et al. Sustained release of a monoclonal antibody from electrochemically prepared mesoporous silicon oxide Adv Funct Mater 20 2010 4168 4174
18. S.P. Low, K.A. Williams, L.T. Canham, and N.H. Voelcker Evaluation of mammalian cell adhesion on surface-modified porous silicon Biomaterials 27 2006 4538 4546
19. E.J. Anglin, L. Cheng, W.R. Freeman, and M.J. Sailor Porous silicon in drug delivery devices and materials Adv Drug Deliv Rev 60 2008 1266 1277
20. E.C. Wu, J.S. Andrew, L.Y. Cheng, W.R. Freeman, L. Pearson, and M.J. Sailor Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles Biomaterials 32 2011 1957 1966
21. R.C. Mundargi, S. Srirangarajan, S.A. Agnihotri, S.A. Patil, S. Ravindra, and S.B. Setty et al. Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon- caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies J Control Release 119 2007 59 68
22. J. Panyam, and V. Labhasetwar Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles Mol Pharm 1 2004 77 84
23. K.R. Yoon, Y.S. Chi, K.B. Lee, J.K. Lee, D.J. Kim, and Y.J. Koh et al. Surface-initiated, ring-opening polymerization of p-dioxanone from gold and silicon oxide surfaces J Mater Chem 13 2003 2910 2914
24. J.M. Chan, L.F. Zhang, K.P. Yuet, G. Liao, J.W. Rhee, and R. Langer et al. PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery Biomaterials 30 2009 1627 1634
25. D.M.K. Jensen, D. Cun, M.J. Maltesen, S. Frokjaer, H.M. Nielsen, and C. Foged Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation J Control Release 142 2010 138 145
26. J. Liu, Z.Y. Qiu, S.Q. Wang, L. Zhou, and S.M. Zhang A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity Biomed Mater 5 2010
27. D.M. Fan, E. De Rosa, M.B. Murphy, Y. Peng, C.A. Smid, and C. Chiappini et al. Mesoporous silicon-PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering Adv Funct Mater 22 2012 282 293
28. M.L. Ho, Y.C. Fu, G.J. Wang, H.T. Chen, J.K. Chang, and T.H. Tsai et al. Controlled release carrier of BSA made by W/O/W emulsion method containing PLGA and hydroxyapatite J Control Release 128 2008 142 148
29. S.N. Garcia, L. Gutierrez, and A. McNulty Real-time cellular analysis as a novel approach for in vitro cytotoxicity testing of medical device extracts J Biomed Mater Res Part A 101 2013 2097 2106
30. J.M. Xue, and M. Shi PLGA/mesoporous silica hybrid structure for controlled drug release J Control Release 98 2004 209 217
31. C.L. Huang, T.W.J. Steele, E. Widjaja, F.Y.C. Boey, S.S. Venkatraman, and J.S.C. Loo The influence of additives in modulating drug delivery and degradation of PLGA thin films Npg Asia Mater 5 2013
32. N. Samadi, A. Abbadessa, A. Di Stefano, C.F. van Nostrum, T. Vermonden, and S. Rahimian et al. The effect of lauryl capping group on protein release and degradation of poly(d, l-lactic-co-glycolic acid) particles J Control Release 172 2013 436 443
33. Q. Xu, S.E. Chin, C.H. Wang, and D.W. Pack Mechanism of drug release from double-walled PDLLA(PLGA) microspheres Biomaterials 34 2013 3902 3911
34. A.L. Silva, R.A. Rosalia, A. Sazak, M.G. Carstens, F. Ossendorp, and J. Oostendorp et al. Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation Eur J Pharm Biopharm 83 2013 338 345
35. M. Gajendiran, S. Divakar, N. Raaman, and S. Balasubramanian In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA-PEG-PLGA triblock copolymeric nanospheres Curr Drug Deliv 10 2013 722 731
36. A.R. Ahmed, K. Elkharraz, M. Irfan, and R. Bodmeier Reduction in burst release after coating poly(d, l-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer Pharm Dev Technol 17 2012 66 72
37. Y.T. Liao, K.C.W. Wu, and J.S. Yu Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy J Biomed Mater Res B 102 2014 293 302
38. X.M. Bian, S. Liang, J. John, C.H. Hsiao, X. Wei, and D. Liang et al. Development of PLGA-based itraconazole injectable nanospheres for sustained release Int J Nanomed 8 2013 4521 4531
39. T.J. Barnes, K.L. Jarvis, and C.A. Prestidge Recent advances in porous silicon technology for drug delivery Ther Deliv 4 2013 811 823
40. D.M. Aragon, J.E. Rosas, and F. Martinez Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres J Microencapsul 30 2013 218 224
41. A.R. Ahmed, A. Dashevsky, and R. Bodmeier Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems Eur J Pharm Biopharm 70 2008 765 769
42. S. Mao, J. Xu, C. Cai, O. Germershaus, A. Schaper, and T. Kissel Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres Int J Pharm 334 2007 137 148
43. F. Cui, D. Cun, A. Tao, M. Yang, K. Shi, and M. Zhao et al. Preparation and characterization of melittin-loaded poly (dl-lactic acid) or poly (dl-lactic-co-glycolic acid) microspheres made by the double emulsion method J Control Release 107 2005 310 319